Delivery Order SPE2DB22D1106-SPE2DB24FEHD6
- Not listed
- This federal contract award, valued at $1,724.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564589702 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to support the DLA's mission to provide logistics and acquisition services to the U.S. Armed Forces and other government agencies. The contract has a firm fixed price pricing type and an ultimate completion date of May...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,184.89 for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $3,682.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567697977 VYVANSE 30 MG CAPSULES 100S, with a firm fixed price and an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $3,516.78, is for the delivery of 4,566,526,139 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $2,525.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4567807523 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of April 7, 2025 and a firm fixed price pricing type. Amerisourcebergen Drug Corp is a for-profit organization and a major pharmaceutical distributor that provides medical products to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,161.44, is for the delivery of 4567332045 VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. Amerisourcebergen is the prime contractor, and there is no set-aside designation...
- This federal contract award, with a ceiling value of $6,966.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a division of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the provision of VYVANSE 30 MG CAPSULES 100s, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $3,356.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of March 20, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,358.10 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567410765 VYVANSE 30 MG CAPSULE 100S and has a completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as...
- This contract award, valued at $2,074.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4566606245 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEHD6Delivery Order
This contract award, valued at $3,905.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of 4564097876 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which enables Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/27/24 |